Work

Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction

Year: 2019

Type: article

Study design: Observational Study

Source: JACC Heart Failure

DOI: 10.1016/j.jchf.2019.05.016

Authors: Yevgeniy Khariton, Gregg C. Fonarow, Suzanne V. Arnold, Ann Hellkamp, Michael E. Nassif, Puza P. Sharma, Javed Butler, Laine Thomas, Carol I. Duffy, Adam D. DeVore, Nancy M. Albert, J. Herbert Patterson, Fredonia B. Williams, Kevin McCague, John A. Spertus

Institutions: Saint Luke's Health System, Saint Luke's Hospital, University of Missouri–Kansas City, University of California, Los Angeles, Ronald Reagan UCLA Medical Center, Los Angeles Medical Center, Duke University, Duke Clinical Research Institute, Washington University in St. Louis, University of Mississippi Medical Center, Duke Medical Center, Cleveland Clinic, University of North Carolina at Chapel Hill

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Heart Association, Boehringer Ingelheim, Abbott Laboratories, Amgen, AstraZeneca, Merck, Novartis, Medtronic, American College of Cardiology Foundation, Gilead Sciences, Novartis Pharmaceuticals Corporation, Bayer Fund, European Commission, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, Janssen Pharmaceuticals

Awards: CARDIOVASCULAR OUTCOMES RESEARCH TRAINING PROGRAM, Mississippi Center for Clinical and Translational Research

OpenAlex ID: W2972424360

FWCI: 5.423

Cites: 27

Cited by: 53

Related to: 10